<DOC>
	<DOCNO>NCT00689039</DOCNO>
	<brief_summary>The purpose study safety tolerability increase dos AZD1305 medication metabolise body ( take , distribute , disappear body ) . The study perform healthy volunteer .</brief_summary>
	<brief_title>Study Extended Release ( ER ) Tablet , Single Repeated Dosing</brief_title>
	<detailed_description />
	<criteria>A body mass index ( BMI=weight/height2 ) 19 27 kg/m2 Clinically normal physical finding , laboratory value rest ECG judge investigator ECG finding outside normal range Potassium outside normal reference value</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>AZD1305</keyword>
	<keyword>safety</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>multiple ascending dos</keyword>
	<keyword>Safety pharmacokinetics</keyword>
</DOC>